Phenomix Sciences: Funding, Investors & Team (Sep 2026)
Using the science of phenotyping, which explains how genes along with environmental and behavioural factors can influence obesity treatment approaches, Phenomix Sciences is an obesity biotechnology pioneer dedicated to eradicating obesity on a global scale. Drs. Acosta and Camilleri, physicians, scientists, and researchers at the Mayo Clinic, launched the business with the belief that unprecedented access to clinical and molecular data on obesity at all phases and phenotypes of the illness is the key to understanding it. Phenomix uses data intelligence to improve its ability to forecast each patient's reaction to a particular weight-loss intervention and lower the variability in patients' weight-loss outcomes.
Phenomix Sciences has raised $5.8M across 3 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Dec 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phenomix Sciences Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Phenomix Sciences Funding Rounds
Phenomix Sciences raised $1.0M in an undisclosed round announced in Feb 2023.
1.3 years later, an undisclosed round of $2.3M was announced in May 2024.
1.6 years later, an undisclosed round of $2.5M was announced in Dec 2025.
Phenomix Sciences Founders and Leadership Team
Contact details for the Phenomix Sciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Phenomix Sciences Funding Compared to Other Biotechnology Startups
Phenomix Sciences' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phenomix Sciences in Biotechnology and Rochester
Companies Similar to Phenomix Sciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Phenomix Sciences Funding FAQs
What does Phenomix Sciences do?
Using the science of phenotyping, which explains how genes along with environmental and behavioural factors can influence obesity treatment approaches, Phenomix Sciences is an obesity biotechnology pioneer dedicated to eradicating obesity on a global scale. Drs. Acosta and Camilleri, physicians, scientists, and researchers at the Mayo Clinic, launched the business with the belief that unprecedented access to clinical and molecular data on obesity at all phases and phenotypes of the illness is the key to understanding it. Phenomix uses data intelligence to improve its ability to forecast each patient's reaction to a particular weight-loss intervention and lower the variability in patients' weight-loss outcomes.
How much funding has Phenomix Sciences raised?
Phenomix Sciences has raised $5.8M across 3 rounds on record. The most recent is an undisclosed round of $2.5M announced in Dec 2025.
When did Phenomix Sciences last raise funding?
Phenomix Sciences' most recent funding round on record is an undisclosed round of $2.5M, announced in Dec 2025.
Who founded Phenomix Sciences?
FundedIQ lists Andres Acosta (Founder), Michael Camilleri (Founder) at Phenomix Sciences.
Where is Phenomix Sciences headquartered?
Phenomix Sciences is based in Rochester, Minnesota, United States.
How many employees does Phenomix Sciences have?
Phenomix Sciences is in the 1-10 employee band.
How does Phenomix Sciences' funding compare to other Biotechnology startups?
Phenomix Sciences' latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Phenomix Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phenomix Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.